Responses
Regular and Young Investigator Award Abstracts
Cell Therapies
194 Pre-clinical development of CT-1119, a mesothelin targeting chimeric antigen receptor macrophage (CAR-M), for solid tumor immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.